VIRIDIAN THERAPEUTICS INC (VRDN) Stock News
USA - NASDAQ:VRDN - US92790C1045 - Common Stock
27.5 USD
+3.08 (+12.61%)
27.49 USD
-0.01 (-0.04%)
VRDN Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Zacks Investment Research - Mentions: BFRI
2 days ago - By: Viridian Therapeutics, Inc.
3 days ago - By: Zacks Investment Research - Mentions: IVVD
4 days ago - By: Viridian Therapeutics, Inc.
17 days ago - By: Benzinga
6 months ago - By: Benzinga
16 days ago - By: Viridian Therapeutics, Inc.
17 days ago - By: Viridian Therapeutics, Inc.
18 days ago - By: Viridian Therapeutics, Inc.
a month ago - By: Viridian Therapeutics, Inc.
2 months ago - By: Viridian Therapeutics, Inc.
2 months ago - By: Viridian Therapeutics, Inc.
3 months ago - By: The Motley Fool
3 months ago - By: Zacks Investment Research - Mentions: FATE
3 months ago - By: Viridian Therapeutics, Inc.
3 months ago - By: Viridian Therapeutics, Inc.
4 months ago - By: Viridian Therapeutics, Inc.
5 months ago - By: Viridian Therapeutics, Inc.
6 months ago - By: Viridian Therapeutics, Inc.
6 months ago - By: Viridian Therapeutics, Inc.
6 months ago - By: Zacks Investment Research - Mentions: IOVA
6 months ago - By: Viridian Therapeutics, Inc.
6 months ago - By: Viridian Therapeutics, Inc.
7 months ago - By: Viridian Therapeutics, Inc.
8 months ago - By: Viridian Therapeutics, Inc.
8 months ago - By: Viridian Therapeutics, Inc.
9 months ago - By: Viridian Therapeutics, Inc.
10 months ago - By: Viridian Therapeutics, Inc.
